Articles

Dr Patz remembered

Arnall Patz, MD, might not have had instant name recognition among most Americans, but among ophthalmologists, he was a legend.

Although it would appear neuroprotective agents for glaucoma will not be available any time soon, research in Alzheimer?s disease and in animal models of glaucoma is generating findings that suggest several promising approaches.

The safety and efficacy of corneal collagen cross-linking with topical riboflavin and UV-A irradiation for the treatment of keratoconus and ectasia after refractive surgery is being investigated in a US clinical trial. Data from an interim analysis of eyes that have reached the 3-month follow-up visit are encouraging.

Addition Technology, Inc., the maker of Intacs corneal implants, AlphaSphere orbital implants and the AlphaCor artificial cornea has received FDA approval for an expanded range of additional sizes of Intacs corneal implants for keratoconus.

Carl Zeiss Meditec has announced that ReLEx, the first femtosecond-only method of laser vision correction, is now available for sale outside the United States.1 ReLEx is a new application that allows ophthalmic surgeons to perform a variety of complete laser vision correction procedures using only the VisuMax Femtosecond laser.

Heidelberg Engineering is introducing SPECTRALIS, then office-based imaging device for tracking and measuring axonal change, at the 2010 meeting of the American Academy of Neurology in Toronto.

Highlights from an expert roundtable meeting can be found in the April issue of Ophthalmology Times Europe.

The Review of Ophthalmology recently published a survey amongst surgeons which indicates that toric IOLs are becoming more popular for managing astigmastism in cataract patients. The results also demonstrated a move away from bimanual surgery and the mixing of presbyopic IOLs.